Evidence map›Paper›PMID 29930027›Full record

ArticleGenome announcements2018

Complete Sequences of the Human T-Cell Leukemia Virus Type 1 Proviral Genomes from Newly Established Adult T-Cell Leukemia Cell Lines in Oita Prefecture, Japan.

Takuro Fukumoto, Emi Ikebe, Masao Ogata, Kazuhiro Kohno, Madoka Kuramitsu, Yusuke Sato, Nichole Fife, Takashi Matsumoto, Takaaki Yahiro, Masanori Ikeda and 12 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Genome announcements, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Takuro Fukumoto *Department of Microbiology, Faculty of Medicine, Oita University, Yufu, Japan.
Emi Ikebe *Department of Microbiology, Faculty of Medicine, Oita University, Yufu, Japan.
Masao OgataDepartment of Medical Oncology & Hematology, Faculty of Medicine, Oita University, Yufu, Japan.
Kazuhiro KohnoDepartment of Medical Oncology & Hematology, Faculty of Medicine, Oita University, Yufu, Japan.
Madoka KuramitsuDepartment of Safety Research on Blood and Biological Products, National Institute of Infectious Diseases, Musashimurayama, Tokyo, Japan.ORCID https://orcid.org/0000-0002-3064-5219
Yusuke SatoDepartment of Microbiology, Faculty of Medicine, Oita University, Yufu, Japan.
Nichole FifeDepartment of Microbiology, Faculty of Medicine, Oita University, Yufu, Japan.
Takashi MatsumotoDepartment of Microbiology, Faculty of Medicine, Oita University, Yufu, Japan.
Takaaki YahiroDepartment of Microbiology, Faculty of Medicine, Oita University, Yufu, Japan.
Masanori IkedaDivision of Persistent and Oncogenic Viruses, Center for Chronic Viral Diseases, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.
Shuichi KusanoDivision of Persistent and Oncogenic Viruses, Center for Chronic Viral Diseases, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.
Akihiko OkayamaDepartment of Rheumatology, Infectious Diseases and Laboratory Medicine, Faculty of Medicine, University of Miyazaki, Kiyotake, Miyazaki, Japan.
Mitsuo HoriDepartment of Hematology, Ibaraki Prefectural Central Hospital, Kasama, Ibaraki, Japan.
Naoki HijiyaDepartment of Molecular Pathology, Faculty of Medicine, Oita University, Yufu, Japan.
Yoshiyuki TsukamotoDepartment of Molecular Pathology, Faculty of Medicine, Oita University, Yufu, Japan.
Yuka HirashitaDepartment of Molecular Pathology, Faculty of Medicine, Oita University, Yufu, Japan.
Masatsugu MoriyamaDepartment of Molecular Pathology, Faculty of Medicine, Oita University, Yufu, Japan.
Kamruddin AhmedDepartment of Pathobiology and Medical Diagnostics, Faculty of Medicine and Health Sciences, University Malaysia Sabah, Kota Kinabalu, Malaysia.
Hiroo HasegawaDepartment of Laboratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Akira NishizonoDepartment of Microbiology, Faculty of Medicine, Oita University, Yufu, Japan.
Masumichi SaitoDepartment of Safety Research on Blood and Biological Products, National Institute of Infectious Diseases, Musashimurayama, Tokyo, Japan saitomas@nih.go.jp hiha@oita-u.ac.jp.
Hidekatsu IhaDepartment of Microbiology, Faculty of Medicine, Oita University, Yufu, Japan saitomas@nih.go.jp hiha@oita-u.ac.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report two complete proviral genome sequences of human T-cell leukemia virus type 1 (HTLV-1) isolated from the peripheral blood specimens of acute type adult T-cell leukemia (ATL) patients in Oita Prefecture, Japan.

Identifiers

PMID29930027
PMCPMC6013615

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.